GT Shareholder David Dykeman, Co-Managing Shareholder of the firm's Boston office and Co-Chair of global Life Sciences & Medical Technology Group, will be a speaker during Exponent's webinar, "Infection Prevention for Medical Products: What You Need to Know," on Thursday, November 4. The growth of drug-resistant microbes and hospital-acquired infections that can result in complications, morbidity, and death is concerning to healthcare providers. Infection prevention is critical for medical device manufacturers, as medical devices can harbor drug-resistant microbes and transmit device-related infections – even after the devices have been disinfected. FDA has responded to increased infection rates associated with reprocessed devices like duodenoscopes by placing new and additional obligations on manufacturers to verify that product designs reduce the risk of cross-contamination and infections.
This webinar will address:
- Causes of Medical Device Infections
- Design Strategies for Infection Prevention for Single Use and Reusable Devices
- Intellectual Property (IP) and Environmental Concerns
- Design Verification for Infection Prevention